Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name ALZHEON, INC Proposed Ticker ALZH CUSIP 00168L101 Business Description A clinical stage biopharmaceutical company with a Phase 3-ready program in Alzheimer’s disease and a discovery platform of small molecules for the inhibition of protein misfolding in neurodegenerative disorders Lead Underwriter ThinkEquity, a division of Fordham Financial Management, Inc Co-Managers The Benchmark Company, LLC Initial Shares 2,500,000 Revised Initial Shares 6,000,000 Initial Price $13.00-$15.00 Revised Price $4.00-$6.00 Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.